Effect of interleukins response to ECM-induced acquisition of drug resistance in MCF-7 cells

Experimental Oncology

Volumn 30, Issue 4, 2008, Pages 276-282

  Ohbayashi, M ^a   Yasuda, M ^a   Kawakami, I ^a   Kohyama, N ^a   Kobayashi, Y ^a   Yamamoto, T ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Caco 2; Cell cell adhesion; Drug resistance; ECM; MCF 7; Spheroid cells

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXANILIDE; BETA TUBULIN; BOVINE SERUM ALBUMIN; CAMPTOTHECIN; COLLAGEN TYPE 1; CYTOKINE; FIBRONECTIN; INTEGRIN; INTERLEUKIN 6; INTERLEUKIN 8; MATRIGEL; MONOCLONAL ANTIBODY; PACLITAXEL; REAGENT; UNCLASSIFIED DRUG; VITRONECTIN; ANTINEOPLASTIC AGENT; INTERLEUKIN DERIVATIVE;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CELL STRAIN MCF 7; CELL STRUCTURE; CELL SURVIVAL; CHILD PARENT RELATION; CHROMATIN CONDENSATION; COLONY FORMATION; CYTOTOXICITY; DRUG EFFECT; DRUG RESISTANCE; EXTRACELLULAR MATRIX; IC 50; IMMUNOFLUORESCENCE; MICROTUBULE ASSEMBLY; PHASE CONTRAST MICROSCOPY; PROTEIN PROTEIN INTERACTION; SPHEROID CELL; BREAST TUMOR; CELL PROLIFERATION; COLON TUMOR; CULTURE TECHNIQUE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LUNG TUMOR; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CAMPTOTHECIN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERLEUKINS; LUNG NEOPLASMS; PACLITAXEL;

EID: 61449561797     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Basson MD, Modlin IM, Madri JA. Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest 1992; 90: 15-23.
2. Borrirukwanit K, Lafleur MA, Mercuri FA, et al. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells. Matrix Biol 2007; 26: 291-305.
3. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
4. Hodkinson PS, Elliott T, Wong WS, et al. ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small cell lung cancer cells through beta 1 integrin-dependent activation of PI3-kinase. Cell Death Differ 2006; 13: 1776-1788
5. Du XP, Plow EF, Frelinger AL, et al. Ligands "activate" integrin αIIbβ3 (platelet GPIIb-IIIa). Cell 1991; 65: 409-416
6. Giltay JC, van Mourik JA. Structure and function of endothelial cell integrins. Haemostasis 1988; 18: 376-389
7. Smith JW, Piotrowicz R, Mathis D. A mechanism for divalent cation regulation of β3 integrins. J Biol Chem 1994; 269: 960-967
8. Meredith JE, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4: 953-961
9. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667
10. Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985; 260: 14873-14878
11. Wang JC. Recent studies of DNA topoisomerases. Biochim Biophys Acta 1987; 909: 1-9.
12. Di Nicolantonio F, Mercer SJ, Knight LA, et al. Cancer cell adaptation to chemotherapy. BMC Cancer 2005; 5: 78-94.
13. Bhalla K, Huang Y, Tang C, et al. Characterization of a human myeloid leukemia cell line highly resistant to taxol. Leukemia 1994; 8: 465-475
14. Casazza AM, Fairchild CR. Paclitaxel (Taxol): mechanisms of Resistance. Cancer Treat Res 1996; 87: 149-171
15. Schibler MJ, Cabral F. Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin. J Cell Biol 1986; 102: 1522-1531
16. Giannakakou P, Sackett DL, Kang YK, et al. Paclitaxelresistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 1997; 272: 17118-17125
17. Damiano JS, Cress AE, Hazlehurst LA, et al. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 1999; 93: 1658-1667
18. Rintoul RC, Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci 2002; 102: 417-424
19. Yasuda M, Shimizu S, Tokuyama S, et al. A novel effect of polymorphonuclear leukocytes in the facilitation of angiogenesis. Life Sci 2000; 66: 2113-2121
20. Toda S, Mastumura S, Yonemitsu N, et al. Effects of various types of extracellular matrices on adhesion, proliferation, differentiation, and c-fos protein expression of porcine thyroid follicle cells. Cell Struct Funct 1995; 20: 345-354
21. Scantena M, Giachelli C. The αvβ3 integrin, NF-kB, osteoprotegrin endothelial cell survival pathway. Trends Cardiovasc Med 2002; 12: 83-88
22. Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978; 273: 345-349
23. Ben-Ze'ev A, Farmer S, Penman S. Protein synthesis requires cell-surface contact while nuclear events respond to cell shape in anchorage-dependent fibroblasts. Cell 1980; 21: 365-372
24. Lohi J, Leivo I, Oivula J, et al. Extracellular matrix in renal cell carcinomas. Histol Histopathol 1998; 13: 785-796
25. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-893
26. Re F, Zanetti A, Sironi M, et al. Inhibition of anchorage- dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994; 27: 537-546
27. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. PNAS USA 1995; 92: 6161-6165
28. Hirtenlehne K, Pec M, Kubista E, Singer CF. Extracellular matrix proteins influence phenotype and cytokine expression in human breast cancer cell lines. Eur Cytokine Netw 2002; 13: 234-240
29. Kobayashi H, Man S, Graham CH, et al. Acquired multicellular-mediated resistance to alkylating agents in cancer. PNAS USA 1993; 90: 3294-3298
30. Hoffman RM. The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro? Cancer Metastasis Rev 1994; 13: 169-173
31. Sakata K, Kwok TT, Gordon GR, et al. Resistance to verapamil sensitization of multidrug-resistant cells grown as multicellular spheroids. Int J Cancer 1994; 59: 282-286
32. Duan Z, Feller AJ, Penson RT, et al. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: Analysis of IL-6, IL-8 and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Clin Cancer Res 1999; 5: 3445-3453
33. Larjava H, Peltonen J, Akiyama SK, et al. Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol 1990; 110: 803-815
34. Manfredi JJ, Horwitz SB. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 1984; 25: 83-125.
35. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 1990; 82: 1247-1259
36. Ahmed AA, Mills AD, Ibrahim AEK, et al. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 2007; 12: 514-527
37. Duan Z, Lamendola DE, Penson RT, et al. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells. Cytokine 2002; 17: 234-242